March 31, 2025 - 11:03
LUXEMBOURG & LONDON & NEW YORK & BOSTON, March 31, 2025—A significant advancement in the field of Assisted Reproductive Technology (ART) has been announced with the launch of Nexpring Health. This new brand identity represents a global MedTech company formed through strategic acquisitions by a prominent pan-European private equity firm. The company consolidates the strengths of Hamilton Thorne, Cook Medical’s Reproductive Health business, and the forthcoming acquisition of FUJIFILM Irvine Scientific’s Medical Media Business.
Nexpring Health aims to enhance the ART landscape by integrating innovative technologies and services that support fertility treatments. The merger of these established entities positions Nexpring Health as a leader in the industry, equipped to deliver cutting-edge solutions to healthcare providers and patients alike. With a focus on improving outcomes in reproductive health, Nexpring Health is set to redefine the standards of care and accessibility in ART, fostering hope for families seeking to expand their futures.
